Cheaper Alternatives to Henry Meds: 2026 GLP-1 Providers Compared

Last reviewed: September 8, 2026 Last updated: September 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Henry Meds charges $297 per month for injectable compounded semaglutide on a month-to-month basis, verified September 4, 2026. PlexusDx charges $189 per month month-to-month for the same medication and route—$108 less per month—and $149 per month on a six-month plan, a difference of $1,296 over twelve months when comparing the lowest available rate at each provider ($1,788 at PlexusDx versus $2,364 at Henry Meds on their respective twelve-month-equivalent plans). Both providers include medication, provider visits, shipping, and supplies at the stated price, with zero membership fees. Henry Meds wins on oral semaglutide ($249/month month-to-month versus PlexusDx $289/month) and offers liraglutide injection at $179/month, which PlexusDx does not carry. PlexusDx offers injectable tirzepatide at $289/month month-to-month; Henry Meds offers oral tirzepatide only. The clearest alternative-cost advantage for most patients appears on injectable semaglutide, where PlexusDx costs 36 percent less month-to-month and 24 percent less over twelve months on prepaid plans.

At-a-glance: Henry Meds versus PlexusDx pricing

Henry Meds figures verified July 20, 2026 and September 4, 2026; PlexusDx figures verified July 20, 2026. Prepaid rates are per-month equivalents requiring full upfront payment. Twelve-month costs are our calculation.

Injectable semaglutide: PlexusDx costs less at every commitment level

Injectable semaglutide is the most-prescribed GLP-1 medication and the clearest point of comparison between these two providers. Henry Meds charges $297 per month on a month-to-month basis, verified September 4, 2026. Over twelve months at that rate, total cost is $3,564 (our calculation: 12 × $297). PlexusDx charges $189 per month month-to-month—$108 less per month—for a twelve-month cost of $2,268 (our calculation: 12 × $189), a difference of $1,296.

Both providers offer prepaid multi-month plans that reduce the effective monthly rate. Henry Meds offers a six-month plan requiring $1,482 paid in full, an amount that works out to $247 per month, and a twelve-month plan requiring $2,364 paid in full, an amount that works out to $197 per month (verified September 4, 2026). PlexusDx offers a three-month plan at $507 total ($169 per month equivalent) and a six-month plan at $894 total ($149 per month equivalent), verified July 20, 2026. Over twelve months at the lowest available rate at each provider—renewing the twelve-month plan once at Henry Meds, or renewing the six-month plan twice at PlexusDx—Henry Meds costs $2,364 and PlexusDx costs $1,788 (our calculation: 2 × $894), a difference of $576 in favor of PlexusDx even when comparing prepaid-to-prepaid.

Both prices include medication, provider visits, shipping, and injection supplies. Neither provider charges a membership fee. Both work with compounding pharmacies; Henry Meds sources from 503A and outsourcing facilities (verified September 8, 2026), while PlexusDx works exclusively with 503A pharmacies (verified July 20, 2026). Both require payment only after a licensed provider approves the prescription.

Oral semaglutide: Henry Meds costs less

Henry Meds offers compounded semaglutide in two oral formats: sublingual tablets at $249 per month month-to-month, and "Premium" tablets or drops at $179 per month month-to-month (verified September 4, 2026). Over twelve months, the sublingual option costs $2,988 (our calculation: 12 × $249). Henry Meds also offers a twelve-month prepaid plan for the sublingual format at $1,788 paid in full, an amount that works out to $149 per month.

PlexusDx offers oral semaglutide capsules at $289 per month month-to-month (verified July 20, 2026), which is $40 per month more expensive than Henry Meds' sublingual tablets and $110 per month more expensive than Henry Meds' Premium format. Over twelve months, PlexusDx oral semaglutide costs $3,468 (our calculation: 12 × $289), compared to Henry Meds' twelve-month prepaid sublingual cost of $1,788—a $1,680 difference in favor of Henry Meds when comparing the lowest available rate at each provider.

The medication formats differ: Henry Meds' sublingual tablets dissolve under the tongue, and the Premium format is described as oral drops. PlexusDx oral semaglutide is delivered as capsules. All three are compounded formulations; absorption kinetics and bioavailability may differ from injectable semaglutide and from one another, though head-to-head efficacy data for these specific compounded formats is not publicly available.

Tirzepatide: PlexusDx offers injection, Henry Meds offers oral only

PlexusDx offers compounded tirzepatide injection at $289 per month month-to-month and $249 per month on a six-month plan (verified July 20, 2026). Over twelve months at the six-month rate, total cost is $2,988 (our calculation: 12 × $249).

Henry Meds does not offer injectable tirzepatide. It offers compounded oral tirzepatide as a dissolving tablet, sold exclusively as a three-month supply requiring $891 paid upfront, an amount that works out to $297 per month (verified September 4, 2026). Over twelve months, renewing the three-month supply four times totals $3,564 (our calculation: 4 × $891).

The source material for Henry Meds oral tirzepatide contains an internal inconsistency: one section describes the product as delivered every sixty days for six months, while pricing indicates a three-month supply. We advise confirming the supply term and delivery cadence at checkout before committing.

Injectable tirzepatide and oral tirzepatide are different routes of administration. Injectable tirzepatide mirrors the FDA-approved Mounjaro and Zepbound formulations (though compounded tirzepatide is not FDA-approved and is not interchangeable with those drugs). Oral tirzepatide is an experimental compounded format; publicly available efficacy and safety data specific to oral tirzepatide formulations is limited.

Liraglutide: Henry Meds only, with pricing conflicts

Henry Meds offers compounded liraglutide injection at $179 per month month-to-month (verified September 4, 2026). PlexusDx does not offer liraglutide. Liraglutide is an older GLP-1 receptor agonist marketed as Saxenda for weight management; it requires daily injection, unlike semaglutide (weekly) or tirzepatide (weekly). Clinical trials demonstrate modest weight loss with liraglutide—typically five to ten percent of body weight—compared to ten to fifteen percent with semaglutide and fifteen to twenty-two percent with tirzepatide in registration trials of the branded drugs.

Henry Meds' prepaid liraglutide pricing shows conflicts in the source material captured September 4, 2026. The six-month plan displays both a $1,074 total ($179/month equivalent) and a $894 total ($149/month equivalent). The twelve-month plan displays both a $2,148 total ($179/month equivalent) and a $1,428 total ($119/month equivalent). We advise confirming the correct prepaid rate at checkout if you are considering liraglutide.

Fees, inclusions, and cancellation

Neither Henry Meds nor PlexusDx charges a membership fee (verified July 20, 2026 and September 4, 2026). Both include medication, provider visits, shipping, and injection supplies (syringes, needles, or auto-injector pens depending on formulation) in the stated monthly price. Both offer a free initial evaluation and charge only if a prescription is approved.

PlexusDx offers an optional gene-drug interaction testing add-on for $298 (or $99 for program members), which includes a complimentary check-in with a licensed pharmacist to review results (verified July 20, 2026). Henry Meds does not advertise genetic testing in the reviewed materials.

Henry Meds allows cancellation at any time via the account portal, email (ask@henrymeds.com), or phone (909-787-2342), verified September 8, 2026. Patients on multi-month prepaid plans may be required to pay the remaining balance unless a medical reason determined by the provider prevents continuation. PlexusDx cancellation terms were not detailed in the sources reviewed for this comparison; contact PlexusDx support to confirm cancellation and refund policies before committing to a prepaid plan.

Medication sourcing and compounding disclosures

Henry Meds sources compounded medications from 503A compounding pharmacies and outsourcing facilities (verified September 8, 2026). Its website states: "Compounded medications do not undergo pre-market review or an FDA-approval process. They may differ in efficacy, safety, risk, and side-effect profiles from commercially available or FDA-approved drugs."

PlexusDx works with licensed 503A compounding pharmacies (verified July 20, 2026). Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Neither provider's compounded semaglutide, tirzepatide, or liraglutide is FDA-approved, interchangeable with, or "the same as" branded drugs such as Ozempic, Wegovy, Mounjaro, Zepbound, or Saxenda. Compounded formulations may differ in potency, purity, stability, and side-effect profile from FDA-approved products.

Choose Henry Meds if…

• You prefer oral semaglutide and want the lowest available month-to-month rate ($249/month for sublingual tablets, or $179/month for Premium drops, versus PlexusDx $289/month for capsules).
• You want a twelve-month prepaid oral semaglutide plan at $1,788 total ($149/month equivalent), which is $1,680 less than PlexusDx oral semaglutide over the same period.
• You are interested in liraglutide injection, which PlexusDx does not offer.
• You want the option of oral tirzepatide (dissolving tablet) and are willing to commit to a three-month supply at $891 upfront, understanding that injectable tirzepatide is not available and that the supply-term language in Henry Meds' source materials contains inconsistencies you should confirm at checkout.

Choose PlexusDx if…

• You want injectable semaglutide and prefer the lowest month-to-month rate with no prepayment ($189/month versus Henry Meds $297/month, a $108/month or $1,296/year difference).
• You want the lowest cost injectable semaglutide over twelve months, even when comparing prepaid plans ($1,788 at PlexusDx on the six-month plan renewed twice, versus $2,364 at Henry Meds on the twelve-month plan).
• You want injectable tirzepatide, which Henry Meds does not offer; PlexusDx charges $289/month month-to-month or $249/month on a six-month plan.
• You prefer to work exclusively with 503A compounding pharmacies rather than a mix of 503A and outsourcing facilities.
• You value the option of gene-drug interaction testing with a licensed pharmacist consultation ($99 for program members).

Methodology and freshness

Henry Meds pricing and service details were verified from the provider's public website on July 20, 2026, September 4, 2026, and September 8, 2026. PlexusDx pricing and service details were verified from PlexusDx's public website on July 20, 2026. Twelve-month cost calculations are our own, derived by multiplying monthly rates or prepaid totals by the number of billing cycles required to cover twelve months. We label all such derived figures as "our calculation." Where source conflicts appear—specifically Henry Meds oral tirzepatide supply term and liraglutide prepaid pricing—we state the conflict plainly and advise readers to confirm at checkout. No patient testimonials, clinician interviews, or first-hand program experience inform this comparison; it relies exclusively on publicly documented commercial terms captured on the dates noted.

Frequently Asked Questions

Is PlexusDx injectable semaglutide actually cheaper than Henry Meds month-to-month?

Yes. PlexusDx charges $189 per month for injectable semaglutide on a month-to-month basis, verified July 20, 2026. Henry Meds charges $297 per month for the same medication and route, verified September 4, 2026. That is a $108 per month difference, or $1,296 over twelve months at the month-to-month rate.

Does Henry Meds offer injectable tirzepatide?

No. Henry Meds offers compounded oral tirzepatide as a dissolving tablet, sold as a three-month supply for $891, but does not offer injectable tirzepatide. PlexusDx offers injectable tirzepatide at $289 per month month-to-month or $249 per month on a six-month plan.

Which provider has the lower cost for oral semaglutide?

Henry Meds costs less. Its sublingual semaglutide tablets are $249 per month month-to-month, and its twelve-month prepaid plan costs $1,788 total ($149/month equivalent), verified September 4, 2026. PlexusDx oral semaglutide capsules cost $289 per month month-to-month, verified July 20, 2026, with no multi-month discount specified in the sources reviewed.

Do either of these providers charge membership fees?

No. Both Henry Meds and PlexusDx include medication, provider visits, shipping, and supplies in the stated monthly price and charge zero membership fees, verified July 20, 2026 and September 4, 2026. Both charge only after a licensed provider approves the prescription.

Are compounded semaglutide and tirzepatide FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not interchangeable with Ozempic, Wegovy, Mounjaro, or Zepbound. A licensed clinician determines whether a compounded prescription is appropriate for an individual patient.

Sources

• PlexusDx public pricing and service details, accessed July 20, 2026
• Henry Meds public website, pricing and medication availability, accessed July 20, 2026
• Henry Meds public website, compounding disclosures and cancellation terms, accessed September 4, 2026
• Henry Meds public website, updated pricing verification across all medication formats, accessed September 8, 2026
• PlexusDx Trustpilot profile, rating and review distribution, accessed September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.